An Evaluation of Glycemic Control Effects of Mono Therapy CKD-501 in Patients With Type 2 Diabetes Mellitus: A 24-week, Multi Center, Randomized, Double-blind, Parallel-group, Placebo Control, Therapeutic Confirmatory Study.
Phase of Trial: Phase III
Latest Information Update: 25 Sep 2013
At a glance
- Drugs Lobeglitazone (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Chong Kun Dang
- 10 Jun 2017 Biomarkers information updated
- 25 Sep 2013 Results presented at the 49th Annual Meeting of the European Association for the Study of Diabetes.
- 25 Jun 2013 Results presented at the 73rd Annual Scientific Sessions of the American Diabetes Association.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History